๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 24 Guangzhou 11 Fuzhou 7 Hangzhou 7 Shanghai 7
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing24 Guangzhou11 Fuzhou7 Hangzhou7 Shanghai7
All 36 locations
Target enrolment
to

Trials with a site in Hangzhou

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery
NCT07576517Older Patients, Surgery, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
1,160
Beijing, Fuzhou, Shenzhen, Xi'an, Hangzhou
2026-06
Not yet open
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery
NCT07576543Older Patients, Surgery, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
1,160
Beijing, Fuzhou, Shenzhen, Xi'an, Hangzhou
2026-06
Recruiting
Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
NCT04744506Breast Cancer, Surgery, Lymph Node Metastases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
126
Hangzhou
2024-11-30
Not yet open
Semi-elemental Versus Polymeric EEN in the Preoperative Optimization for Patients with CD
NCT06587178Crohn Disease, Nutrition Disorders, Surgery
Wei Zhou
Not applicable
304
Hangzhou
2024-10-01
Recruiting
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
NCT06760221Soft Tissue Sarcoma, Stereotactic Body Radiotherapy, Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
20
Hangzhou
2023-03-23
Recruiting
Diagnosis and Treatment of Foreign Bodies Outside Pharynx and Esophagus Lumen
NCT04917367Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
50
Hangzhou
2021-07-02
Recruiting
A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
NCT06353672Liver Diseases, Surgery
Zhejiang University
Not applicable
1,000
Hangzhou
2020-12-01
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Hangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Hangzhou?

4 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hangzhou), 7 studies
PhaseStudiesRecruitingShare
Not applicable4357.1%
Phase 42028.6%
Observational1114.3%

Most active sponsors

Lead sponsors with the most studies (Hangzhou)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine33
Peking University First Hospital20
Wei Zhou10
Zhejiang University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.